John C. Pepia
Net Worth
Last updated:
What is John C. Pepia net worth?
The estimated net worth of Mr. John C. Pepia is at least $9,783,509 as of 10 Nov 2021. He owns shares worth $1,609,489 as insider, has earned $1,778,820 from insider trading and has received compensation worth at least $6,395,200 in Pediatrix Medical Group, Inc..
What is the salary of John C. Pepia?
Mr. John C. Pepia salary is $799,400 per year as Senior Vice President & Chief Accounting Officer in Pediatrix Medical Group, Inc..
How old is John C. Pepia?
Mr. John C. Pepia is 62 years old, born in 1963.
What stocks does John C. Pepia currently own?
As insider, Mr. John C. Pepia owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | Senior Vice President & Chief Accounting Officer | 96,666 | $16.65 | $1,609,489 |
What does Pediatrix Medical Group, Inc. do?
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
John C. Pepia insider trading
Pediatrix Medical Group, Inc.
Mr. John C. Pepia has made 11 insider trades between 2017-2021, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of MD stock worth $142,250 on 10 Nov 2021.
The largest trade he's ever made was exercising 10,000 units of MD stock on 2 Sep 2021. As of 10 Nov 2021 he still owns at least 96,666 units of MD stock.
Pediatrix Medical Group key executives
Pediatrix Medical Group, Inc. executives and other stock owners filed with the SEC:
- Dr. Roger J. Medel (78) Co-Founder & Director
- Dr. Roger Mack Hinson M.D. (61) Pres of Pediatrix & Obstetrix Medical Groups
- Mr. C. Marc Richards (54) Executive Vice President, Chief Financial Officer & Principal Accounting Officer
- Mr. Dominic J. Andreano (56) Executive Vice President, Gen. Counsel & Sec.
- Mr. John C. Pepia (62) Senior Vice President & Chief Accounting Officer
- Mr. Mark S. Ordan (66) Chief Executive Officer & Director